Samsung Biologics Holds Annual General Meeting... John Lim: "Becoming an End-to-End Partner"
All Five Agenda Items, Including Amendments to Articles of Incorporation, Approved as Originally Proposed
Samsung Biologics held its 15th Annual General Meeting of Shareholders on the 20th at Incheon Songdo Convensia.
At the meeting, five agenda items were proposed: approval of the financial statements, amendments to the articles of incorporation, appointment of inside directors, appointment of audit committee members and outside directors, and approval of the limit on directors’ remuneration. All five items were approved as originally proposed.
In his welcoming remarks, CEO John Lim stated, "Last year, through a spin-off, we became a pure CDMO (Contract Development and Manufacturing Organization), resolving concerns over conflicts of interest among our clients. We also secured a global production base by deciding to acquire the Rockville facility in the United States." He added, "We have focused on expanding our portfolio, including the launch of organoid services and securing land for the third Bio Campus to respond to new modalities (therapeutic approaches)."
John Rim, CEO of Samsung Biologics, is speaking at the 15th Annual General Meeting held at Songdo Convensia in Incheon on the 20th.
View original imageThis year’s meeting was conducted both in person and via live online broadcast, with approximately 1,400 shareholders participating. To enhance shareholder convenience, the company supported the exercise of voting rights by conducting electronic voting for ten days from the 10th to the 19th.
CEO John Lim and Gyun Roh, Head of EPCV Center, were reappointed as inside directors. Jungyeon Kim, a professor at Ewha Womans University Law School, was newly appointed as an outside director and audit committee member.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
CEO John Lim said, "We will successfully complete the acquisition of the U.S. facility and quickly establish it as a core base for global production. We will also proceed without delay in constructing our second and third Bio Campuses in Korea." He added, "Beyond CMO (Contract Manufacturing Organization) services, we will further strengthen our CDO (Contract Development Organization) competitiveness, as well as our capabilities in antibody-drug conjugates (ADC), organoids, and more, to become an end-to-end partner that satisfies global clients."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.